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Abstract
The role of regulatory T cells (Tregs) in bacterial sepsis remains controversial because antibody-mediated depletion
experiments gave conflicting results. We employed DEREG mice (DEpletion of REGulatory T cells) and a caecal ligation and
puncture model to elucidate the role of CD4+Foxp3+ Tregs in sepsis. In DEREG mice natural Tregs can be visualized easily
and selectively depleted by diphtheria toxin because the animals express the diphtheria toxin receptor and enhanced green
fluorescent protein as a fusion protein under the control of the foxp3 locus. We confirmed rapid Treg-activation and an
increased ratio of Tregs to Teffs in sepsis. Nevertheless, 24 h after sepsis induction, Treg-depleted and control mice showed
equally strong inflammation, immune cell immigration into the peritoneum and bacterial dissemination. During the first
36 h of disease survival was not influenced by Treg-depletion. Later, however, only Treg-competent animals recovered from
the insult. We conclude that the suppressive capacity of Tregs is not sufficient to control overwhelming inflammation and
early mortality, but is a prerequisite for the recovery from severe sepsis.
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Introduction
Sepsis remains a major cause of death in intensive care units
worldwide [1]. Especially postoperatively acquired abdominal
sepsis due to intestinal leakage is still associated with a very high
lethality of about 60% [2].
During the last years, increasing attention has been directed at
the role of the adaptive immune system, since it became apparent
that T cells can strongly influence the course of the disease even in
the first days of sepsis [3–6]. One T cell subpopulation became a
major focus of interest: natural regulatory T cells (Tregs). These
cells have been shown to be of central importance for the
maintenance of immune homeostasis and self-tolerance. Their
ablation leads to catastrophic autoimmune disease in mice and
humans [7–10]. During infection Tregs can prevent excessive
immunopathology and increase survival under some conditions
[11–13], whereas in other circumstances the dampening effects of
natural Tregs may interfere with protective immune responses
[14–17]. Thus Tregs are a double-edged sword in infection,
limiting inflammation and collateral tissue damage at the price of
interference with bacterial clearance [15,17]. Therefore, as a
prerequisite for possible therapeutic intervention, it is important to
understand whether Tregs have a beneficial or deleterious impact
on the outcome of abdominal sepsis.
Yet, studies on Treg function in sepsis using CD25 to
characterize Tregs yield conflicting results. In the caecal ligation
and puncture (CLP) model of murine sepsis, Heuer et al. reported
improved survival after adoptive transfer of small numbers of ex
vivo activated CD4+CD25+ Tregs [18]. Following Treg depletion
with anti-CD25 mAbs, other groups observed no effect [19,20] or
even improved survival in murine sepsis [21]. One has to bear in
mind that CD25 is not exclusively expressed on Tregs but is
rapidly induced on naı¨ve T cells and T effector cells (Teffs) upon
activation. On the other hand, a significant proportion of Foxp3+
Tregs does not express CD25 [22–24]. The anti-CD25 antibody
(PC61), which has been used in many studies on Tregs, will not
deplete this Foxp3+CD252 subpopulation and is only partially
efficient in depleting CD25+ Tregs [25]. Furthermore, the
antibodies remain in the system for several days and could then
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affect Teffs, which become activated within hours upon sepsis
induction [3,26].
To overcome these experimental constraints, researchers have
recommended using the transcription factor Foxp3 as a marker for
Tregs when exploring how these cells shape the immune response
in sepsis [17,27]. It has been well documented, that Foxp3 is
selectively expressed by CD4+ regulatory T cells in the murine
system [28–33] as well as by a small subpopulation of CD8+ cells.
The latter have been attributed with a role in autoimmune
disorders [31–35], graft-versus-host disease [36–38] and they
suppressed immune responses against malignancies [39,40].
Foxp3+ cells are defined as bona fide Tregs in this manuscript.
We have taken advantage of DEREG mice (DEpletion of
REGulatory T cells), which express a primate diphtheria toxin
receptor fused to enhanced green fluorescent protein (eGFP) under
the control of the foxp3 promoter [9]. This enabled us to visualize
Foxp3+ Tregs ex vivo and to selectively deplete them in vivo. We
employed the caecal ligation and puncture (CLP) model of sepsis
to examine changes in Treg phenotype and function in
generalized bacterial infection. Similar to the human disease,
CLP causes rapid systemic inflammation as a consequence of the
continuous dissemination of endogenous gut bacteria [41].
After sepsis induction, Tregs were rapidly activated systemically
and showed enhanced suppressive capacity in vitro. However,
depletion of Foxp3+ Tregs did not change early mortality, but
decreased survival in late disease. Adoptive transfer of pre-
activated Tregs before sepsis induction did not improve the
outcome.
Materials and Methods
Animal experiments and ethics statement
DEREG mice were on a C57BL/6 genetic background. These
mice are heterozygous for a diphtheria toxin receptor-eGFP
construct under the control of the foxp3 promoter [9]. C57BL/6
wild type (WT) mice served as controls. The mice were housed in a
conventional, temperature-controlled animal facility with a 12-
hour light/12-hour dark cycle and provided with food and water
ad libitum. All experiments were performed according to the
German animal safety regulations and approved by the animal
ethics committee of the local animal protection authority (LALLF,
Landesamt fu¨r Landwirtschaft, Lebensmittelsicherheit und
Fischerei Mecklenburg-Vorpommern). During experimental pro-
cedures, the animals were provided with food and water ad
libitum. All efforts were made to minimize suffering.
Peritoneal sepsis model – caecal ligation and puncture
(CLP)
Female mice, 8–12 weeks old, were anaesthetized with
Ketamin/Xylazin (100 mg/10 mg per kg bodyweight). The
caecum was ligated 1.3 cm above the distal ending and punctured
once at the anti-mesenteric side with an 18 G needle. The mice
received 0.3 ml 0.9% NaCl i.p. for volume substitution.
Survival and disease severity were monitored every 3 h for 72 h
by an observer who was blinded for the treatments applied.
Disease severity was scored on the basis of (1) general appearance,
(2) breathing frequency, (3) spontaneous and (4) provoked
behaviour. Scoring points from 0 = healthy to 3 = severe
alteration were given for each item and then summed up [42].
If the mice reached a severity score that indicated a disease point
of no return, these mice were euthanized by cervical dislocation
under deep anaesthesia.
Depletion of regulatory T cells
For in vivo Treg depletion, 1 mg diphtheria toxin (DT; Merck,
Darmstadt, Germany) dissolved in 100 ml phosphate buffered
saline (PBS) was administered intravenously to DEREG mice on
days 22 and 21 before the CLP operation. Depletion of the Treg
cell population was confirmed by flow cytometry and histology
and reached an efficiency of about 95% in the spleen, mesenteric
lymph node, thymus, and blood (Figure S1).
Determination of the bacterial load
24 h after CLP, the mice were put into deep anaesthesia and
sacrificed by cervical dislocation. Spleen and liver were obtained.
The homogenized organ suspensions were incubated on Columbia
blood agar (Becton Dickinson, Heidelberg, Germany) for 22 h at
37uC. Bacterial colonies were enumerated and related to organ
weight.
Antibodies for flow cytometry
Peritoneal lavage and spleen cell suspensions were obtained as
described before [3]. The following fluorochrome-labelled or
unlabelled antibodies were purchased from BD Biosciences
(Heidelberg, Germany): aCD4 (RM4–5), aCD69 (H1.2F3),
hamster aCTLA-4 (UC10-4F10-11), aLy6G (1A8), aCD11b
(M1/70), a biotinylated cocktail of mAbs against Armenian and
Syrian hamster IgG, and aCD11c (HL3). Antibodies directed
against MHC-II (M5/114.15.2), CD3 (145-2C11), F4/80 (BM8),
CD25 (PC61.5) and CD19 were from eBioscience (Hatfield, UK).
For intracellular Foxp3 staining, we used Foxp3-mAb (3G3) and
the FoxP3-Staining Buffer Set from MiltenyiBiotec (Bergisch
Gladbach, Germany). Streptavidin-Alexa647 was obtained from
Invitrogen.
Cytokine expression
To determine serum concentrations of IL-6, TNFa, MCP-1,
IFN-c, IL12p70, and IL-10, a mouse inflammation cytometric
bead array kit (BD, San Diego, USA) was used according to the
manufacturer’s instructions.
Isolation of Tregs, Teffs and antigen presenting cells
Splenic CD4+ T cells from DEREG mice were negatively
selected by magnetic cell sorting (MACS) with the CD4+ T cell
isolation Kit II, MACS MiltenyiBiotec. Afterwards the eGFP-
expressing Tregs and the eGFP-negative Teffs were sorted with a
fluorescence-activated cell sorter (FACS), FACSAria. In general
we obtained Tregs of about 98% purity and .70% viability. Teff
purity was about 95% and viability was 94% (Figure S2 A and B).
CD11c+ antigen-presenting cells (APC) with a purity of 93%
(Figure S2C) were isolated with the CD11c-Microbeads-Kit,
MiltenyiBiotec. Before seeding the APC onto culture plates, they
were irradiated with 30 Gray.
Adoptive transfer of activated Tregs
DEREG mice received 250 mg of a superagonistic anti-CD28
monoclonal antibody (aCD28 SA, clone D665) in the lateral tail
vein three days before they were sacrificed under deep anaesthesia
by cervical dislocation and their spleens explanted. aCD28 SA has
been shown to increase Treg numbers and activation status [43].
In vivo pre-activated Tregs as well as Tregs and Teffs from
untreated animals were isolated as described above. 36105 cells
were transferred into the lateral tail vein of female C57BL/6 mice
directly before CLP.
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Proliferation assay
56104 isolated Teffs were co-incubated for 72 h with 16104
irradiated APC, varying numbers of Tregs and 1 mg/ml soluble
anti-CD3 antibody (eBioscience). 3H-Thymidine was added for
the last 17 h of culture, and incorporation was measured in counts
per minute (cpm).
Statistical analysis
Statistical analyses were performed using GraphPad Prism 5 for
Windows (GraphPad software, San Diego, CA, USA). Survival
was analysed with Kaplan-Meier survival curves and compared
with the log rank test. Bacterial loads, cytokine concentrations and
expression of activation markers were assessed for significant
differences using ANOVA with Bonferroni posttest for selected
pairs. Differences in the suppressive capacity of Tregs isolated
from septic vs non-septic animals were compared with a non-
parametric t-test. P-values ,0.05 were considered to be signifi-
cant.
Results
Activation of Foxp3+ Tregs and Foxp32 Teffs in sepsis
To address the impact of sepsis on natural Tregs, we subjected
DEREG mice to CLP and measured the proportion of Foxp3+
cells in the CD4+ T cell population. Twenty-four hours after sepsis
induction, the percentage of CD4+Foxp3+ splenocytes was
significantly increased (Figure 1A). As previously observed in
Figure 1. CLP rapidly activated CD4+T cells and increased the percentage of the Foxp3+ Treg subpopulation. DEREG mice were
subjected to 18G CLP or left untreated. Twenty-four hours later the percentage of Foxp3+ cells in the CD4+ T cell subpopulation and the absolute
numbers of CD4+Foxp3+ and CD4+Foxp32 cells of the spleen were determined (A). In addition, the expression of the activation markers CTLA4, CD69,
and CD25 on Foxp3+ Tregs (B) and Foxp32 Teffs (C) was assessed (GMFI, geometric mean fluorescence intensity). The means are indicated. n = 5 mice/
group. * p,0.05; ** p,0.01.
doi:10.1371/journal.pone.0065109.g001
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human and murine sepsis [44,45], this shift in the Treg/Teff ratio
was probably due to the relative resistance of Tregs to apoptosis
[44,46] rather than to Treg expansion because the total number of
CD4+Foxp3+ Tregs in the spleen was not significantly altered (data
not shown). In addition, Tregs strongly upregulated the markers
CTLA-4, CD69 and CD25, indicating that they were activated
within hours after sepsis induction (Figure 1B). The Foxp32 Teffs
were also rapidly activated (Figure 1C).
Tregs increased their suppressive potential in sepsis
Some groups have reported enhanced suppressor activity of
Tregs 24 h after sepsis induction [19], while other groups did not
find changes in suppressive Treg activity earlier than three days
after sepsis [20,47]. We observed significantly enhanced suppres-
sor activity in in vitro co-culture assays already 24 h after CLP.
Foxp3+ Tregs from septic mice potently suppressed the activation
of Teffs from both untreated and septic animals. The relative
increase of suppressor activity was most pronounced when Teffs
from septic mice were targeted (Figure 2) clearly showing that
during sepsis Teffs did not become inherently resistant to the
inhibitory effects of Tregs.
Treg depletion reduced sepsis survival
To test how these activated suppressive Foxp3+ Tregs influence
the outcome of sepsis, we depleted Tregs from the system before
sepsis induction. In contrast to other studies worldwide, we did not
use a depleting antibody, but treated DEREG mice with DT to
selectively deplete Tregs. DT-treated C57BL/6 WT mice served
as controls.
Both groups showed similar survival kinetics until 36 h post-
CLP (Figure 3A). Thereafter, the curves split. 25% of Treg-
competent but only 5% of Treg-depleted animals survived. This
was mirrored by the disease severity. After 36 h Treg-competent
animals began to recover, while Treg-depleted animals continued
to deteriorate (Figure 3B).
Treg depletion did not alter peritoneal leukocyte
migration, bacterial clearance or serum cytokine
production
Twenty-four hours after CLP we measured an increase of
peritoneal cell content (Figure 4A). This was mainly due to an
increase of absolute neutrophil and inflammatory monocyte
counts, while flow cytometric analysis revealed a decrease of B
cells and resident peritoneal macrophages. There was no
difference between Treg-depleted and non-depleted mice
(Figure 4B–E). The bacterial loads in spleen and liver (Figure 5)
as well as the proinflammatory serum cytokine concentrations,
which strongly increased following CLP, were also indistinguish-
able between Treg-depleted and non-depleted mice (Figure 6).
Adoptive transfer of pre-activated Tregs did not alter
survival after sepsis
In sepsis Tregs became activated and showed enhanced
suppressive capacity. However, in vivo they were not able to
improve mortality at early time points. We wondered whether an
adoptive transfer of pre-activated Tregs could support endogenous
Tregs in suppressing hyperinflammtion in the early phase. Since
activation of purified Tregs in vitro led to pronounced apoptosis
([48] and not shown), we pre-activated Tregs in vivo by
administering 250 mg of a CD28 superagonistic antibody to
DEREG mice. Within three days, this treatment increased the
number of splenic Foxp3+ Tregs threefold and strongly activated
the cells (Figure S3A, B). In a two-step isolation procedure (see
materials and methods), the eGFP+ splenic Tregs were enriched to
.95% purity. They were .70% viable and had increased
suppressive potential when co-cultured with Foxp32 Teffs from
untreated animals (Figure S3C). In vivo pre-activated Tregs (36105)
were adoptively transferred (i.v.) into WT mice immediately after
purification and directly before CLP-surgery. Control mice
received untreated Tregs or Teffs. The adoptively transferred
pre-activated Tregs did not significantly alter CLP survival
(Figure 7).
Figure 2. Foxp3+ Tregs maintained their suppressive capacity after CLP. CD4+Foxp32 Teffs (56104) were isolated 24 h after 18G CLP (A) or
from untreated C57BL/6 mice (B) and co-incubated at the given ratios with CD4+Foxp3+ Treg isolated from CLP-treated (filled bars) or untreated
DEREG mice (open bars). They were cultured for 72 h in the presence of 16104 irradiated APCs and 1 mg/ml soluble anti-CD3 antibody. 3H-Thymidine
was added for the last 17 h of culture, and incorporation was measured as counts per minute (cpm). Cpm of Teff without Treg was set to 100%.
Means +/2 SEM are indicated. One of two independent experiments with similar results is shown. Differences between the suppressor activity of
Tregs from septic and non-septic mice were tested for significance at each effector-suppressor ratio (t-test). * p,0,5; *** p,0.001.
doi:10.1371/journal.pone.0065109.g002
Role of Tregs in Murine Abdominal Sepsis
PLOS ONE | www.plosone.org 4 May 2013 | Volume 8 | Issue 5 | e65109
Discussion and Conclusion
Experiments with CD25-specific antibodies for depleting
Foxp3+ Tregs have yielded conflicting results in sepsis studies
[19–21]. Conclusions from these studies are limited because, on
one hand activated Teffs also express CD25, and on the other
hand many Tregs do not express CD25. Therefore, we opted for
DEREG-mice who at present are the best available experimental
system to visualize Foxp3+ Tregs and deplete them selectively
without the need for antibodies.
In DEREG animals, depletion of Foxp3+ Tregs by DT was
almost complete (92–98%). Not surprisingly it has been shown that
Figure 3. Treg-depletion augmented disease severity and decreased survival in CLP-treated mice. DEREG and C57BL/6 mice pre-treated
with DT (1 mg in 100 ml PBS i.v. on days 22 and21) were subjected to CLP. Survival was monitored for 5 days (A) and disease severity was scored for
3 days (B) by an observer blinded for the group assignment. Data from four independent experiments with similar results are summarized (each
experiment involved 8–11 mice/group). Median and interquartile range of the disease severity score are shown in panel B; ** p,0.01.
doi:10.1371/journal.pone.0065109.g003
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Figure 4. Depletion of Tregs did not alter cell migration into the peritoneum. DEREG and C57BL/6 mice pre-treated with DT (1 mg in 100 ml
PBS i.v. on days 22 and 21) were subjected to CLP (n = 7–9 mice/group) or left untreated (n = 5 mice/group). Cells from the peritoneal cavity were
harvested by peritoneal lavage 24 h after CLP. The total number of cells was enumerated and related to volume of recovered lavage fluid (A). The
numbers of B cells (CD19+) (B), neutrophils (Ly6G+) (C), peritoneal macrophages (F4/80+CD11b+MHCII+) (D) and inflammatory monocytes (F4/
80-CD11b+MHCIIlo) (E) was assessed via flow cytometry. Means are shown.
doi:10.1371/journal.pone.0065109.g004
Figure 5. No influence of Treg depletion on bacterial dissemination in CLP-treated mice. DEREG and C57BL/6 mice pre-treated with DT
(1 mg in 100 ml PBS i.v. on days 22 and21) were subjected to CLP (n = 3–7 mice/group) or left untreated (n = 3–5 mice/group). Liver and spleen were
recovered from Treg-depleted and non-depleted mice 24 h after CLP. Tissue homogenates were incubated on Columbia blood agar for 22 h at 37uC.
Colony-forming units (CFUs) were related to organ weight. Means are shown.
doi:10.1371/journal.pone.0065109.g005
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Foxp32 Tregs are unaffected [9,49,50], which limits the scope of
this study. Control WT mice were not affected by DT treatment.
Using a similar sepsis model, the colon ascendens stent peritonitis
[42], we have compared two types of controls, WT mice receiving
DT and DEREG mice treated with saline only, and did not
observe differences regarding immune cell immigration into the
peritoneum, bacterial dissemination nor serum cytokine concen-
trations (unpublished observation).
The vast majority of the depleted Foxp3+ cells are CD4+ bona
fide Tregs. A contribution of Foxp3+ CD8+ T cells to the resolution
of sepsis symptoms cannot be excluded but is probably minor, as
they make up 0.1–0.4% of the CD8+ T cell pool and only 2% of
the total Foxp3+ population [51]. Furthermore, Foxp3+ CD8+ T
cells apparently lack potent suppressive capacity in vitro, even
though they share phenotypic features with classical CD4+ Tregs
[51].
An additional concern was the potential influence of cell death.
Although the clinical picture of diphtheria is associated with
necrosis, DT acts by inhibiting protein biosynthesis and, as a
result, apoptotic cell death without inflammation [26,52].
Hotchkiss et al. showed that apoptotic cells have a mild negative
influence on sepsis outcome, which was accompanied by a
reduction of IFNc secretion following ex vivo stimulation of
splenocytes and also by severely impaired bacterial eradication
[53]. None of this was observed in our system following Treg
depletion. Bacterial dissemination was not affected during the first
24 h of sepsis, and serum concentrations of inflammatory
cytokines, including IFNc, either did not change, or they were
in tendency increased in Treg-depleted septic animals.
In our CLP model of severe abdominal sepsis (75% lethality at
day 5), Foxp3+ Tregs became activated within 24 hours and
displayed enhanced in vitro-suppressive function, which corrobo-
rated our previous findings and those of Scumpia et al. [3,19].
Moreover, Teffs from septic animals did not become inherently
resistant to the inhibitory effects of Tregs as they were even more
readily suppressed ex vivo than Teffs from untreated controls. In
agreement with the observations of other groups, the ratio between
Foxp3+ Tregs and Foxp32 Teff cells was significantly shifted
towards Tregs [19,27,44,54], but the absolute numbers of splenic
Tregs did not change. Apparently, the increase in the Treg
proportion in sepsis is mainly due to their relative resistance to
lymphocyte apoptosis as has been well documented in humans and
mice [44,45,55–58]. In contrast, many Teffs underwent cell death.
It may be speculated that the increased responsiveness to Treg
inhibition ex vivo characterizing Teffs from septic animals could be
the result of Teff selection by cell death. Peripheral conversion of
Teffs into induced Tregs may also increase the relative Treg
numbers. Under our conditions, however, this appears less likely
because in vitro experiments have shown that Treg induction takes
more than 48 h [59–61]. Also, Foxp3 expression in induced CD8+
Tregs is reported to be rather unstable [51].
Thus one day after sepsis induction Foxp3+ Tregs were strongly
activated, increased in proportion relative to Teffs and their in
vitro-suppressive capacity was enhanced. Nevertheless, Treg
depletion did not alter the early course of the disease in our
severe CLP model. Later, however, Foxp3+ Tregs were protective
and improved survival from only 5% in depleted animals to 25%
in Treg-competent mice. Between one and two days after CLP,
Figure 6. Serum cytokines in CLP-treated mice. DEREG and C57BL/6 mice pre-treated with DT (1 mg in 100 ml PBS i.v. on days22 and21) were
subjected to CLP or left untreated. Twenty-four hours later serum cytokine concentrations (IL6, IL10, MCP-1, IFNc, TNFa and IL12p70) increased in
septic animals, but there were no differences between Treg-depleted and non-depleted septic mice. Means are indicated; n = 5–9 mice/group.
doi:10.1371/journal.pone.0065109.g006
Figure 7. Adoptive transfer of in vivo activated Tregs did not improve survival after CLP. DEREG mice received 250 mg CD28 SA i.v. three
days before their spleens were explanted and in vivo pre-activated CD4+Foxp3+ Tregs were isolated. 36105 of those cells were adoptively transferred
into female C57BL/6 recipients (i.v.). (i) Untreated CD4+Foxp3+ and (ii) untreated CD4+Foxp32 cells were transferred as controls. 18G CLP was
performed immediately after the cell transfer and survival was monitored every three hours for three days. The Kaplan-Meier survival curves are
shown. n= 10–11 mice/group.
doi:10.1371/journal.pone.0065109.g007
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Treg-competent survivors began to recover, whereas disease
symptoms continued in the Treg-depleted animals.
Why did Tregs not alter survival on the first day after CLP or
dampen the proinflammatory cytokine response in this study,
although, after removal from the septic microenvironment and
three days in cell culture, they displayed enhanced suppressor
activity? In sepsis the organism is flooded with large amounts of
bacterial compounds that function as microorganism-associated
molecular patterns (MAMPs). Such ligands of pattern recognition
receptors on immune cells may modulate immune suppression
either directly or indirectly. Regarding direct effects, there is
controversy about how TLR ligation affects Treg function [62–
65]. This can be (partially) explained by the kinetics of events. For
example, TLR2 triggering transiently reduced the suppressive
capacity of Tregs, but after the signal had declined, the cells
regained suppressor activity [66,67]. Even more important for
Treg function could be indirect effects of inflammatory cytokines,
such as TNFa and IL6, which are released by immune cells
following MAMP stimulation [68]. In combination these cytokines
impair the suppressive function of Tregs [69–71]. Upon removal
of the microbial compounds and cytokines, the suppressor activity
of Tregs is restored or even enhanced [69]. On the other hand,
activated Tregs might face overwhelming inflammation in sepsis
rendering immune cells refractory to suppression, or the activated
Tregs are simply outnumbered by activated (innate) immune cells.
We therefore adoptively transferred activated Tregs similar to
Heuer et al. [18], who used in vitro-activated Tregs. Since in our
hands isolated Foxp3+ Tregs rapidly died in cell culture
corroborating the reports of Zeng and co-workers [48], we
decided to activate the Tregs in vivo using a CD28 superagonistic
monoclonal antibody [43]. In this manner we avoided the well-
documented effects of necrotic and/or apoptotic cells on the
course of the disease [53,72,73]. After pre-activation in DEREG
mice, the brightly fluorescent Foxp3+ cells could be enriched to
very high purity and immediately transferred into the experimen-
tal animals at good viability. The transferred cells had a
remarkable suppressive potential in cell culture (Figure S3), but
they did not alter the fate of animals subjected to CLP. Whereas
Heuer and co-workers reported a protective effect with as few as
36104 in vitro activated CD4+CD25+ Tregs [18], in our
experiments even the transfer of 36105 in vivo pre-activated
Foxp3+ Tregs did not improve survival. This could be due to a loss
of the pre-activated state of exogenous Tregs upon adoptive
transfer into septic animals or a refractory state of endogenous
immune cells.
It appears that in severe sepsis, activated Foxp3+ Tregs were
initially overwhelmed by inflammatory stimuli. Later in the
disease, however, Tregs had a significant protective effect. These
findings support the model of ‘‘tuned suppression’’, namely the
idea that in a highly inflammatory microenvironment even
activated Tregs transiently lose their suppressive influence, thus
enabling a powerful antimicrobial defence [69,74]. Later, when
the initial cytokine storm has significantly decreased, Tregs regain
their suppressive influence and dampen inflammatory effector
mechanisms thereby minimizing host tissue damage [75–79]. Our
results show that this is important for the recovery from severe
sepsis.
In summary, Treg-depletion worsened late survival, hence
implying a beneficial role for Foxp3+ Tregs in severe sepsis.
Supporting Information
Figure S1 Efficiency of in vivo Treg depletion. Female
DEREG mice received 1 mg DT solute i.v. on two consecutive
days before readout or CLP. Control mice received PBS.
Splenocytes (A) and blood leukocytes (B) were analysed by flow
cytometry for Foxp3 expression in CD4+ T cells. Cryosections
from mesenteric lymph node (C) and thymus (D) were analysed for
CD4 (red) and Foxp3 (green) expression with a fluorescence
microscope. The DT treatment ablated around 95% of the
Foxp3+ T cells. Results from one representative animal are shown.
(PPTX)
Figure S2 Purity of the isolated Tregs, Teffs and APCs.
The increased purity of Tregs and Teffs after MACS column-
based negative CD4+ T cell enrichment and flow cytometric
sorting is shown in A. Foxp3+ Treg preparations were about 98%
pure, 70% of the cells were viable (B). Foxp32 Teffs had a purity
of 95% with a viability of 94% (B). APCs were sorted with MACS
columns based on CD11c. Preparations were 90% CD11c+ cells
(C). For purity and viability staining, the following reagents were
used: CD4-Alexafluor647 (Gk1.5), CD11c-FITC (HL3) and an
AnnexinV-PE apoptosis detection kit from BD Biosciences.
(PPTX)
Figure S3 CD28 SA-mediated activation of Tregs in
vivo. DEREG mice received 250 mg CD28 SA i.v. three days
before their spleens were explanted and CD4+Foxp3+ Tregs
isolated. Control mice were left untreated or received an isotype
control antibody (MOPC-31C). CD28 SA treatment increased the
numbers of splenic Tregs and Teffs (A) and increased CTLA-4
expression by Tregs (B). To test for functional activity (C), 56104
untreated CD4+Foxp32 Teffs were co-incubated at the given ratio
with CD4+Foxp3+ Tregs that were either untreated (open bars) or
pre-activated with CD28SA in vivo (filled bars). They were co-
cultured for 72 h with 16104 irradiated APC and 1 mg/ml soluble
anti-CD3 antibody. 3H-Thymidine was added for the last
17 hours of culture. 3H-Thymidine incorporation (cpm) of Teffs
without Tregs was set to 100%. In vivo CD28 SA treatment
markedly increased the suppressive potential of the Tregs. One out
of two experiments with similar results is depicted. Means +/2
SEM are shown.
(PPTX)
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